INT38371

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.22
First Reported 1986
Last Reported 2009
Negated 2
Speculated 0
Reported most in Body
Documents 2
Total Number 3
Disease Relevance 0.58
Pain Relevance 0.32

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

protein transporter activity (Ap3b1) transport (Ap3b1) vesicle-mediated transport (Ap3b1)
Golgi apparatus (Ap3b1)
Ap3b1 (Mus musculus)
Pain Link Frequency Relevance Heat
amygdala 3 86.80 High High
Hippocampus 3 80.08 Quite High
Enkephalin 4 66.08 Quite High
Nucleus accumbens 1 47.92 Quite Low
Spinal cord 70 7.40 Low Low
cytokine 4 5.00 Very Low Very Low Very Low
Inflammatory response 4 5.00 Very Low Very Low Very Low
Central nervous system 2 5.00 Very Low Very Low Very Low
withdrawal 2 5.00 Very Low Very Low Very Low
Inflammation 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Keloid Scars 22 93.80 High High
Contusions 44 89.36 High High
Severe Combined Immunodeficiency 30 87.60 High High
Injury 226 73.76 Quite High
Diphtheria 12 58.28 Quite High
Spinal Cord Injury 18 50.00 Quite Low
Diabetes Mellitus 2 37.08 Quite Low
Obesity 2 36.72 Quite Low
Toxicity 2 28.76 Quite Low
Drug Induced Neurotoxicity 2 21.80 Low Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The dynamic state of the proenkephalin (PE) gene products during and after development of amygdaloid kindling was assayed by monitoring changes of the accumulation of PE mRNA and changes in proenkephalin-related peptides.
Regulation (changes) of PE mRNA
1) Confidence 0.22 Published 1986 Journal J. Neurosci. Res. Section Abstract Doc Link 3746949 Disease Relevance 0 Pain Relevance 0.32
Additionally, biochemical protein analysis supplemented our stereological quantification and demonstrated no changes in protein expression levels of Fibronectin, NG2, Versican, GFAP, and PE-CAM1 at 2 weeks post-transplant.
Neg (no) Regulation (changes) of PE-CAM1
2) Confidence 0.01 Published 2009 Journal PLoS ONE Section Body Doc Link PMC2690693 Disease Relevance 0.43 Pain Relevance 0
Further, biochemical analyses supplement stereological data and demonstrate no changes in Fibronectin, Versican, GFAP, NG2, and PE-CAM1 protein expression at 2 weeks post-transplant.
Neg (no) Regulation (changes) of PE-CAM1
3) Confidence 0.00 Published 2009 Journal PLoS ONE Section Body Doc Link PMC2690693 Disease Relevance 0.15 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox